Stryker Aktie
384,88USD | -5,17USD | -1,33% |
WKN: 864952 / ISIN: US8636671013
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 93,73 |
The Vanguard Group, Inc. | 8,17 |
Vanguard Group, Inc. (Subfiler) | 8,11 |
John Wilford Brown | 5,26 |
Greenleaf Trust | 4,86 |
State Street Corp. | 3,83 |
Vanguard Total Stock Market ETF | 2,84 |
T Rowe Price Associates, Inc. (13F Subfiler) | 2,77 |
Wellington Management Co. LLP (Wellington Breakout) | 2,57 |
BlackRock Fund Advisors | 2,49 |
Vanguard 500 Index Fund | 2,38 |
BlackRock Institutional Trust Co. NA | 2,04 |
Capital Research & Management Co. (Global Investors) | 1,85 |
Geode Capital Management LLC | 1,81 |
JPMorgan Investment Management, Inc. | 1,78 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 40 000 | 43 000 | 46 000 | 51 000 | 52 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,37 | 0,33 | 0,37 | 0,36 | 0,39 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 11 360 | 9 707 | 10 017 | 10 275 | 12 518 |
Summe Anlagevermögen | 18 807 | 24 623 | 24 614 | 26 609 | 27 394 |
Summe Aktiva | 30 167 | 34 330 | 34 631 | 36 884 | 39 912 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 11 477 | 14 425 | 12 901 | 13 526 | 13 494 |
Summe Fremdkapital | 17 360 | 21 246 | 19 754 | 20 268 | 21 319 |
Summe Eigenkapital | 12 807 | 13 084 | 14 877 | 16 616 | 18 593 |
Summe Passiva | 30 167 | 34 330 | 34 631 | 36 884 | 39 912 |
Adresse
1941 Stryker Way, 49002 Portage | |
Telefon | +1 (269) 385-2600 |
Internet | http://www.stryker.com |
Management
Alan Douville
Chief Information Officer & Vice President |
Allan C. Golston
Independent Director |
Andrew K. Silvernail
Independent Director |
Dana S. McMahon
Chief Compliance Officer & Vice President |
Giovanni Caforio
Independent Director |
Glenn S. Boehnlein
Chief Financial Officer & Vice President |
Howard E. Cox
Director-Emeritus |
Irene B. Corbe
Vice President-Internal Audit |
James Andrew Pierce
Group President-MedSurg & Neurotechnology |
Jason Beach
Vice President-Investor Relations |
Jeanne M. Blondia
Treasurer & Vice President-Finance |
Jody Powell
VP-Global Regulatory Affairs & Quality Assurance |
John Janik
Senior Director-Strategic Development |
John Wilford Brown
Chairman-Emeritus |
Kevin A. Lobo
Chairman, President & Chief Executive Officer |
Lisa M. Skeete Tatum
Independent Director |
M. Kathryn Fink
Chief Human Resources Officer & Vice President |
Mary K. Brainerd
Independent Director |
Michael Panos
President-North America |
Nick Corcoran
Vice President-Division Operations |
Preston Wells
Group CFO & VP-Strykers Orthopaedics |
Rachel Marie Ruggeri
Independent Director |
Rajeev Suri
Independent Non-Executive Director |
Robert Cummings
Vice President-Tax |
Robert Fletcher
Chief Legal Officer & Vice President |
Ronda E. Stryker
Independent Director |
Sherilyn D. McCoy
Lead Independent Director |
Spencer S. Stiles
Group President-Orthopaedics & Spine |
Viju S. Menon
Group President-Global Quality & Operations |
William Edward Berry
Chief Accounting Officer & Vice President |
Yin C. Becker
Chief Corporate Affairs Officer & Vice President |